v3.26.3
Stockholders' Equity
 9 Months Ended
Sep. 30, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders' equity
Common Stock
Underwritten Offering
In the first-quarter 2025, we sold through an underwritten public offering, 13.6 million shares of our common stock at a public offering price of $11.00 per share, for total gross proceeds of approximately $150 million, before deducting underwriting discounts, commissions and offering expenses. As part of this underwritten offering, Gilead purchased 1.4 million shares of our common stock for total gross proceeds of $15 million. See Note 16, Subsequent event, for information on issuances of common stock after September 30, 2026.
At-the-Market Facility
In the third-quarter 2025, we issued and sold under our equity distribution agreement 0.6 million shares of our common stock for total gross and net proceeds of $8 million.